"10.1371_journal.pone.0110047","plos one","2014-10-27T00:00:00Z","Giuseppe Bozza; Mirco Capitani; Paolo Montanari; Barbara Benucci; Marco Biancucci; Vincenzo Nardi-Dei; Elena Caproni; Riccardo Barrile; Benedetta Picciani; Silvana Savino; Beatrice Aricò; Rino Rappuoli; Mariagrazia Pizza; Alberto Luini; Michele Sallese; Marcello Merola","Novartis Vaccines, Siena, Italy; Unit of Genomic Approaches to Membrane Traffic, Fondazione Mario Negri Sud, S. Maria Imbaro (CH), Italy; Institute of Protein Biochemistry, CNR, Naples, Italy; Department of Biology, University of Naples “Federico II”, Naples, Italy","Conceived and designed the experiments: BA SS RR MP AL MS MM. Performed the experiments: GB MC PM BB MB VND EC RB. Analyzed the data: GB MC BB BP MS MM. Wrote the paper: GB MS MM.","PM, VND, SS, BA, RR, and MP are employees of Novartis Vaccines, whose company funded this study. GB, RB, and MB were students working at Novartis and BB is a student still working at Novartis. EC was a post-doctoral fellow working at Novartis. MM is a Novartis Scientific collaborator and was responsible for this project. The antigen of this study is one of the components of Bexsero, a commercially available vaccine against meningococcus B. There are no further patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","10","Giuseppe Bozza","GB",16,TRUE,7,8,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
